COM:KARYOPHARM
Karyopharm Therapeutics Inc.
- Stock
Last Close
0.78
22/11 21:00
Market Cap
107.99M
Beta: -
Volume Today
500.06K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 173K - | 1.50M 764.16% | 3.38M 125.75% | 4.17M 23.41% | 3.63M 12.76% | |||||||
average payables | 1.41M - | 4.01M 185.09% | 5.05M 25.76% | 4.28M 15.22% | 5.21M 21.70% | 5.00M 4.02% | 2.66M 46.81% | 2.72M 2.22% | 3.03M 11.37% | 2.19M 27.71% | 2.95M 34.73% | |
average receivables | 3.93M - | 10.37M 163.84% | 17.69M 70.55% | 34.79M 96.68% | 37.02M 6.42% | |||||||
book value per share | 25.53 - | 6.64 73.99% | 5.57 16.15% | 4.32 22.36% | 2.82 34.77% | 3.23 14.37% | 0.80 75.10% | 0.70 12.67% | -1.06 250.97% | -0.20 80.79% | -1.19 486.15% | |
capex per share | -0.01 - | -0.09 868.92% | -0.04 56.32% | -0.00 95.31% | -0.00 27.59% | -0.04 2,980.97% | -0.00 92.01% | -0.00 39.47% | -0.08 3,673.08% | -0.00 98.10% | ||
capex to depreciation | -0.40 - | -8.77 2,116.59% | -2.23 74.54% | -0.10 95.63% | -0.09 10.93% | -3.21 3,597.21% | -0.21 93.42% | -0.15 29.47% | -7.24 4,752.99% | -0.19 97.38% | ||
capex to operating cash flow | 0.00 - | 0.06 2,827.28% | 0.02 72.66% | 0.00 94.49% | 0.00 1.40% | 0.01 1,665.73% | 0.00 92.73% | 0.00 16.17% | 0.05 5,792.78% | 0.00 98.52% | ||
capex to revenue | -0.15 - | -12.38 8,302.34% | -5.66 54.23% | -0.45 91.97% | -0.04 91.50% | -0.08 101.65% | -0.01 93.53% | -0.00 73.37% | -0.03 1,929.27% | -0.00 97.24% | ||
cash per share | 25.71 - | 6.61 74.30% | 4.93 25.37% | 3.45 29.98% | 3.19 7.58% | 5.78 81.14% | 4.23 26.85% | 3.46 18.18% | 3.04 12.15% | 3.40 11.71% | 0.46 86.53% | |
days of inventory on hand | 52.47 - | 356.77 579.98% | 440.53 23.48% | 295.75 32.86% | 224.75 24.01% | |||||||
days payables outstanding | 149.37 - | 600.46 302.01% | 171.99 71.36% | 194.16 12.89% | 230.65 18.80% | |||||||
days sales outstanding | 70.17 - | 43.50 38.01% | 39.14 10.03% | 109.42 179.58% | 67.39 38.41% | |||||||
debt to assets | 0.00 - | 0.12 - | 0.40 229.35% | 0.38 4.85% | 0.38 1.27% | 0.56 46.82% | 0.48 14.08% | 0.74 52.44% | ||||
debt to equity | 0.01 - | 0.17 - | 0.74 340.52% | 2.24 202.73% | 2.37 5.84% | -2.15 190.84% | -10.39 382.16% | -1.30 87.49% | ||||
dividend yield | ||||||||||||
earnings yield | -0.24 - | -0.07 73.36% | -0.25 285.11% | -0.31 24.07% | -0.29 5.78% | -0.34 14.56% | -0.17 49.89% | -0.18 4.73% | -0.26 45.78% | -0.59 131.44% | -1.45 143.91% | |
enterprise value | -16.90M - | 1.01B 6,103.74% | 413.60M 59.24% | 303.05M 26.73% | 371.64M 22.63% | 516.67M 39.02% | 1.17B 126.19% | 1.15B 1.83% | 462.49M 59.69% | 316.15M 31.64% | 223.59M 29.28% | |
enterprise value over ebitda | 0.50 - | -13.39 2,789.86% | -3.47 74.06% | -2.74 21.21% | -2.85 4.03% | -2.94 3.18% | -6.35 116.34% | -6.80 6.93% | -4.73 30.39% | -2.26 52.23% | -1.73 23.61% | |
ev to operating cash flow | 0.56 - | -19.73 3,634.77% | -4.40 77.70% | -3.59 18.36% | -5.04 40.39% | -3.25 35.59% | -6.12 88.61% | -7.16 16.91% | -4.32 39.70% | -2.11 51.04% | -2.41 14.07% | |
ev to sales | -43.68 - | 4.43K 10,246.06% | 1.65K 62.67% | 1.97K 18.95% | 231.55 88.23% | 17.03 92.64% | 28.58 67.80% | 10.61 62.86% | 2.20 79.23% | 2.01 8.69% | 1.53 23.93% | |
free cash flow per share | -5.00 - | -1.74 65.14% | -2.68 53.70% | -2.25 16.00% | -1.61 28.59% | -2.84 76.93% | -3.08 8.42% | -2.23 27.80% | -1.50 32.62% | -1.83 21.88% | -0.81 55.60% | |
free cash flow yield | -0.22 - | -0.05 78.66% | -0.20 334.19% | -0.24 18.41% | -0.17 30.08% | -0.30 81.27% | -0.16 47.01% | -0.14 10.59% | -0.23 62.22% | -0.54 130.49% | -0.94 74.54% | |
graham net net | 25.16 - | 6.17 75.47% | 4.45 27.88% | 2.97 33.30% | 2.08 29.82% | 3.00 43.84% | 0.37 87.70% | -0.03 108.59% | -1.83 5,670.42% | -0.73 60.27% | -2.65 265.02% | |
graham number | 56.69 - | 19.07 66.36% | 20.39 6.92% | 16.86 17.33% | 13.35 20.77% | 15.10 13.09% | 7.63 49.47% | 6.56 14.06% | 6.27 4.39% | 3.04 51.52% | 5.80 90.72% | |
income quality | 0.89 - | 0.68 23.91% | 0.80 17.19% | 0.77 3.20% | 0.57 25.79% | 0.89 56.05% | 0.96 7.20% | 0.82 14.61% | 0.86 5.74% | 0.90 4.82% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 11.32K - | -75.85K 770.22% | 133.05 100.18% | 85.57 35.68% | 80.73 5.66% | -72.16 189.38% | -12.10 83.24% | -6.33 47.65% | -3.77 40.41% | -5.69 50.78% | 5.44 195.58% | |
interest debt per share | 0.13 - | 0.00 99.98% | -0.03 78,333.67% | -0.03 37.25% | 0.44 1,371.80% | 2.43 454.31% | 2.05 15.58% | 2.04 0.59% | 2.63 28.80% | 2.42 7.98% | 1.34 44.54% | |
inventory turnover | 6.96 - | 1.02 85.29% | 0.83 19.01% | 1.23 48.95% | 1.62 31.59% | |||||||
invested capital | 0.01 - | 0.17 - | 0.74 340.52% | 2.24 202.73% | 2.37 5.84% | -2.15 190.84% | -10.39 382.16% | -1.30 87.49% | ||||
market cap | 139.07M - | 1.17B 737.99% | 471.96M 59.50% | 352.72M 25.27% | 440.64M 24.93% | 532.03M 20.74% | 1.19B 123.24% | 1.12B 6.10% | 483.65M 56.63% | 278.36M 42.45% | 98.80M 64.51% | |
net current asset value | 154.66M - | 194.21M 25.57% | 160.52M 17.35% | 113.49M 29.30% | 97.59M 14.01% | 176.59M 80.95% | 28.48M 83.87% | 27.04M 5.06% | -126.88M 569.32% | -48.08M 62.11% | -142.72M 196.86% | |
net debt to ebitda | 4.59 - | 1.99 56.74% | 0.49 75.34% | 0.45 8.49% | 0.53 17.85% | 0.09 83.48% | 0.10 18.34% | -0.19 283.51% | 0.22 214.17% | -0.27 224.75% | -0.96 256.69% | |
net income per share | -5.59 - | -2.43 56.50% | -3.32 36.33% | -2.92 11.98% | -2.81 3.77% | -3.14 11.81% | -3.22 2.53% | -2.72 15.43% | -1.65 39.45% | -2.02 22.38% | -1.25 37.95% | |
operating cash flow per share | -4.99 - | -1.65 66.90% | -2.64 59.76% | -2.25 14.80% | -1.61 28.59% | -2.80 74.49% | -3.08 9.91% | -2.22 27.79% | -1.42 35.97% | -1.83 28.27% | -0.81 55.56% | |
payables turnover | 2.44 - | 0.61 75.12% | 2.12 249.14% | 1.88 11.42% | 1.58 15.82% | |||||||
receivables turnover | 5.20 - | 8.39 61.32% | 9.33 11.15% | 3.34 64.23% | 5.42 62.36% | |||||||
research and ddevelopement to revenue | 73.52 - | 262.56 257.13% | 390.98 48.91% | 564.53 44.39% | 66.84 88.16% | 5.32 92.04% | 2.99 43.76% | 1.40 53.36% | 0.77 45.06% | 0.95 23.46% | 0.95 0.39% | |
return on tangible assets | -0.21 - | -0.34 60.30% | -0.55 59.50% | -0.61 10.74% | -0.72 17.77% | -0.52 26.91% | -0.68 29.41% | -0.63 7.34% | -0.41 35.17% | -0.46 13.54% | -0.60 28.97% | |
revenue per share | 0.06 - | 0.01 88.47% | 0.01 4.57% | 0.00 41.52% | 0.03 752.00% | 0.53 1,427.91% | 0.66 23.54% | 1.50 127.30% | 2.79 85.93% | 1.92 31.22% | 1.28 33.36% | |
roe | -0.22 - | -0.37 67.24% | -0.60 62.59% | -0.68 13.36% | -1.00 47.51% | -0.97 2.24% | -4.01 311.70% | -3.88 3.16% | 1.56 140.11% | 9.92 537.18% | 1.05 89.41% | |
roic | -0.22 - | -0.37 68.09% | -0.60 62.58% | -0.68 14.71% | -0.86 26.39% | -0.56 34.64% | -1.07 90.42% | -0.94 12.78% | -0.95 1.77% | -0.86 9.63% | -2.76 219.56% | |
sales general and administrative to revenue | 15.21 - | 69.64 357.97% | 86.33 23.96% | 155.51 80.13% | 15.50 90.04% | 1.61 89.61% | 0.69 - | 0.93 35.02% | ||||
shareholders equity per share | 25.53 - | 6.64 73.99% | 5.57 16.15% | 4.32 22.36% | 2.82 34.77% | 3.23 14.37% | 0.80 75.10% | 0.70 12.67% | -1.06 250.97% | -0.20 80.79% | -1.19 486.15% | |
stock based compensation to revenue | 9.78 - | 62.18 535.80% | 68.23 9.72% | 144.69 112.08% | 12.71 91.21% | 0.57 95.52% | 0.37 34.34% | 0.23 39.61% | 0.14 37.14% | 0.23 58.77% | ||
tangible asset value | 154.93M - | 206.79M 33.47% | 198.37M 4.08% | 162.24M 18.21% | 129.46M 20.20% | 183.17M 41.48% | 49.77M 72.83% | 50.55M 1.55% | -79.67M 257.62% | -16.66M 79.09% | -136.21M 717.76% | |
tangible book value per share | 25.53 - | 6.64 73.99% | 5.57 16.15% | 4.32 22.36% | 2.82 34.77% | 3.23 14.37% | 0.80 75.10% | 0.70 12.67% | -1.06 250.97% | -0.20 80.79% | -1.19 486.15% | |
working capital | 155.05M - | 195.45M 26.06% | 162.47M 16.87% | 115.16M 29.12% | 98.96M 14.07% | 287.71M 190.74% | 227.31M 20.99% | 289.24M 27.24% | 184.38M 36.25% | 260.84M 41.47% | 164.44M 36.96% |
All numbers in USD (except ratios and percentages)